N-butyryl-L-Homoserine lactone-d5
(Synonyms: N-丁酰基-L-高丝氨酸内酯 d5) 目录号 : GC47754A neuropeptide with diverse biological activities
Cas No.:2701379-46-4
Sample solution is provided at 25 µL, 10mM.
N-
1.Gould, T.A., Herman, J., Krank, J., et al.Specificity of acyl-homoserine lactone syntheses examined by mass spectrometryJ. Bacteriol.188(2)773-783(2006) 2.Henke, J.M., and Bassler, B.L.Bacterial social engagementsTrends in Cell Biology14(11)648-656(2004) 3.Diggle, S.P., Winzer, K., Lazdunski, A., et al.Advancing the quorum in pseudomonas aeruginosa: MvaT and the regulation of n-acylhomoserine lactone production and virulence gene expressionJournal of Bacteriology184(10)2576-2586(2002) 4.Pessi, G., Williams, F., Hindle, Z., et al.The global posttranscriptional regulator RsmA modulates production of virulence determinants and N-acylhomoserine lactones in pseudomonas aeruginosaJournal of Bacteriology183(22)6676-6683(2001) 5.Hoang, T.T., and Schweizer, H.P.Characterization of pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): A target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesisJournal of Bacteriology181(17)5489-5497(1999) 6.Morohoshi, T., Inaba, T., Kato, N., et al.Identification of quorum-sensing signal molecules and the LuxRI homologs in fish pathogen edwardsiella tardaJournal of Bioscience and Bioengineering98(4)274-281(2004) 7.Luo, Z.Q., Su, S., and Farrand, S.K.In situ activation of the quorum-sensing transcription factor TraR by cognate and noncognate acyl-homoserine lactone ligands: Kinetics and consequencesJournal of Bacteriology186(19)5665-5672(2003)
Cas No. | 2701379-46-4 | SDF | |
别名 | N-丁酰基-L-高丝氨酸内酯 d5 | ||
Canonical SMILES | CCCC(=O)N[C@H]1CCOC1=O | ||
分子式 | C8H8D5NO3 | 分子量 | 176.2 |
溶解度 | DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 30 mg/ml,PBS (pH 7.2): 10 mg/ml | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 5.6754 mL | 28.3768 mL | 56.7537 mL |
5 mM | 1.1351 mL | 5.6754 mL | 11.3507 mL |
10 mM | 0.5675 mL | 2.8377 mL | 5.6754 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet